“Annual funding for research and development (R&D) in the fight against malaria has quadrupled over 16 years, generating the strongest pipeline of potential treatments in history, according to a report [.pdf] on Tuesday,” Reuters reports (Kelland, 6/28).
GAO on Monday published two reports on the government’s response to the 2009 H1N1 influenza pandemic. The first report examines lessons learned from the government’s response that can be incorporated into future planning (6/27). The second report examines how production delays for the H1N1 vaccine “heightened interest in alternative technologies…
In its first decade, the GAVI Alliance has helped prevent the deaths of more than five million children by introducing more widespread vaccination in low-income countries, “[b]ut, going forward, the alliance is going to have to think more about getting parents to vaccinate their kids â€“ the demand side of health â€“ especially if it wants to repeat the huge victory of wiping out a disease” such as smallpox, Charles Kenny writes in his weekly column for Foreign Policy.
In its Morbidity and Mortality Weekly Report, the CDC describes “global public health achievements â€¦ that occurred outside of the United States during 2001-2010.” Gains in public health efforts, such as preventing child mortality, malaria, and neglected tropical diseases, have improved longevity and “resulted from improved living conditions overall, advances in medical science, and a number of population-level interventions. However, major disparities persist. During the past decade, in low-income countries, average life expectancy at birth increased from 55 to 57 years (3.6%), while increasing from 78 to 80 years (2.6%) in high-income countries,” the article notes (6/24).
In a Huffington Post opinion piece, Gro Brundtland, a member of the U.N. Foundation board of directors, former WHO director general and former prime minister of Norway, discusses global progress on childhood vaccines. Brundtland discusses the upcoming launch of the U.N. Foundation’s global vaccines campaign aimed at inspiring Americans “to provide children in the developing world with immunizations against deadly diseases.”
Owen Barder, a visiting fellow at the Center for Global Development, examines the relationship among aid donors, GAVI and pharmaceutical companies in a post on the center’s “Global Health Policy” blog.
Syndicated columnist and ONE senior adviser Michael Gerson, in a CNN opinion piece, reviews the documentary “Voodoo and Vaccines,” which he writes “shows how government and health officials have reached out to religious leaders, and how many traditional healers are now carrying a pro-vaccination message. They are combining a belief in traditional medicine with an acceptance of modern medicine. And this is benefiting the people of Benin.”
As Tachi Yamada, president of global health at the Bill & Melinda Gates Foundation, prepares to leave the foundation this month, Nature News interviewed him about his work at the Gates Foundation and his predictions for global health.
The final phase of testing for GlaxoSmithKline Biologicals’ malaria vaccine, RTS,S, is underway in seven sub-Saharan African countries, and “[i]f the results, due to be released later this, year confirm the vaccine’s efficacy in preventing malaria, it could be made available as early as 2015,” IRIN reports.
The success of antiretroviral therapy for HIV/AIDS “has fooled us into believing HIV is under control. It is not. â€¦ The fact remains that no sexually acquired infection has ever been controlled in democratic societies except by vaccines,” Lawrence Corey, president and director of the Fred Hutchinson Cancer Research Center and principal investigator of the international HIV Vaccine Trials Network, writes in a Wall Street Journal opinion piece.